Gabriele Cerrone
Founder at ACCUSTEM SCIENCES, INC.
Net worth: 33 M $ as of 2024-03-30
Profile
Gabriele Marco Antonio Cerrone is the founder of Cardiff Oncology, Inc. (founded in 1999), FermaVir Pharmaceuticals LLC (founded in 2004), Synergy Pharmaceuticals LLC (founded in 2008), Tiziana Life Sciences Ltd.
(founded in 1998), Rasna Therapeutics, Inc. (founded in 2013), AccuStem Sciences, Inc. (founded in 2020), and Tiziana Life Sciences Ltd.
(founded in 1998).
He is also the founder of Hepion Pharmaceuticals, Inc., Gensignia Ltd., Arna Therapeutics Ltd., Biovitas Capital Ltd., and Gensignia Life Sciences, Inc. Mr. Cerrone's current job(s) include being the Non-Executive Chairman of OKYO Pharma Ltd.
since 2021, Director of Gensignia IP Ltd.
since 2014, and Managing Partner of Panetta Partners Ltd.
since 2005.
His former job(s) include being the Chairman of Callisto Pharmaceuticals, Inc. from 2003 to 2013, Director of SIGA Technologies, Inc. in 2003, Independent Director of Inhibitex LLC from 2007 to 2012, and Managing Director-Investments of Barrington Capital Group LP in 1998.
Mr. Cerrone's education history includes an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TIZIANA LIFE SCIENCES LTD.
38.03% | 2023-04-23 | 38,890,635 ( 38.03% ) | 18 M $ | 2024-03-30 |
OKYO PHARMA LIMITED
27.61% | 2023-10-26 | 9,178,119 ( 27.61% ) | 14 M $ | 2024-03-30 |
ACCUSTEM SCIENCES INC
33.79% | 2022-12-30 | 3,831,223 ( 33.79% ) | 1 M $ | 2024-03-30 |
Gabriele Cerrone active positions
| Companies | Position | Start |
|---|---|---|
| OKYO PHARMA LIMITED | Chairman | 2021-01-06 |
| ACCUSTEM SCIENCES, INC. | Founder | 2020-06-04 |
| TIZIANA LIFE SCIENCES LTD | Chief Executive Officer | 2022-07-31 |
| Gensignia Ltd. | Founder | - |
Gensignia IP Ltd.
 Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Gensignia IP Ltd. is a professional, scientific, and British technical services company. Part of Gensignia Life Sciences, Inc., the private company is based in London, UK. | Director/Board Member | 2014-04-22 |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Founder | - |
| Biovitas Capital Ltd. | Founder | - |
Arna Therapeutics Ltd.
 Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Arna Therapeutics Ltd. is a British biotechnology company that focuses on research and experimental development. The private company was founded by Gabriele Marco Antonio Cerrone. | Founder | - |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Chief Executive Officer | - |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Former positions of Gabriele Cerrone
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Gabriele Cerrone
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| OKYO PHARMA LIMITED | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Private companies | 16 |
|---|---|
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
Panetta Partners Ltd.
 Panetta Partners Ltd. Financial ConglomeratesFinance Panetta Partners Ltd. is a private equity firm that primarily invests in technology companies. | Finance |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Health Technology |
| Barrington Capital Group LP | |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| Gensignia Ltd. | |
Arna Therapeutics Ltd.
Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Arna Therapeutics Ltd. is a British biotechnology company that focuses on research and experimental development. The private company was founded by Gabriele Marco Antonio Cerrone. | Commercial Services |
| Biovitas Capital Ltd. | |
Gensignia Life Sciences, Inc.
Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Health Technology |
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Rasna Therapeutics, Inc. operates as a development stage biotechnology company focused on the development of cancer drugs. It is focused primarily on the development of drug candidates for leukemia and lymphoma. The company was founded by Gabriele Marco Antonio Cerrone, Roberto Pellicciari and Brunangelo Falini in 2013 and is headquartered in San Diego, CA. | Distribution Services |
Gensignia IP Ltd.
Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Gensignia IP Ltd. is a professional, scientific, and British technical services company. Part of Gensignia Life Sciences, Inc., the private company is based in London, UK. | Commercial Services |
| AccuStem Sciences, Inc. | |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Gabriele Cerrone
